Global Pharmaceutical Continuous Manufacturing Market by Product (Integrated Systems, Semi-Continuous Systems), Distribution (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Application, End User - Forecast 2024-2030- Product Image

Sale

Global Pharmaceutical Continuous Manufacturing Market by Product (Integrated Systems, Semi-Continuous Systems), Distribution (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Application, End User - Forecast 2024-2030

Report
186 Pages
March 2024
Region: Global
360iResearch™
ID: 4968719

UP TO €846EUR$875USD£727GBP OFF until Dec 31^st 2024

The Pharmaceutical Continuous Manufacturing Market size was estimated at USD 669.31 million in 2023, USD 753.86 million in 2024, and is expected to grow at a CAGR of 12.61% to reach USD 1,537.65 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pharmaceutical Continuous Manufacturing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pharmaceutical Continuous Manufacturing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Continuous Manufacturing Market, highlighting leading vendors and their innovative profiles. These include 3P Biopharmaceuticals S.L.U. , AC Immune SA, Chemtrix BV, Continuus Pharmaceuticals, Coperion GmbH, Corning Incorporated, Gebrüder Lödige Maschinenbau GmbH, Glatt GmbH, Hosokawa Micron Corporation, Korsch AG, L.B. Bohle Maschinen und Verfahren GmbH, Sanofi S.A., Scott Equipment Company, Siemens AG, SK Biotek Co., Ltd., and Syntegon Technology GmbH.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Continuous Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Integrated Systems
- Semi-Continuous Systems
  - Continuous Blenders
  - Continuous Coaters
  - Continuous Compressors
  - Continuous Dryers
  - Continuous Granulators
Distribution
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Application
- Active Pharmaceutical Ingredient
- Biologics
- Dry Powders
End User
- Contract Manufacturing Organization
- Pharmaceutical Companies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Pharmaceutical Continuous Manufacturing Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pharmaceutical Continuous Manufacturing Market?
What are the technology trends and regulatory frameworks in the Pharmaceutical Continuous Manufacturing Market?
What is the market share of the leading vendors in the Pharmaceutical Continuous Manufacturing Market?
Which modes and strategic moves are suitable for entering the Pharmaceutical Continuous Manufacturing Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Pharmaceutical Continuous Manufacturing Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing production of pharmaceuticals
5.1.1.2. Favorable regulatory policies for adoption of automatic manufacturing systems
5.1.1.3. Increasing application owing to better efficiency of manufacturing operations
5.1.2. Restraints
5.1.2.1. High infrastructural investments and concerns regarding cleaning validation
5.1.3. Opportunities
5.1.3.1. Emerging collaborations between industry and academics
5.1.3.2. Ongoing growth in generic manufacturing
5.1.4. Challenges
5.1.4.1. Dearth of technical and regulatory clarities
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Pharmaceutical Continuous Manufacturing Market, by Product

6.1. Introduction
6.2. Integrated Systems
6.3. Semi-Continuous Systems
6.4.1. Continuous Blenders
6.4.2. Continuous Coaters
6.4.3. Continuous Compressors
6.4.4. Continuous Dryers
6.4.5. Continuous Granulators

7. Pharmaceutical Continuous Manufacturing Market, by Distribution

7.1. Introduction
7.2. Hospital Pharmacy
7.3. Online Pharmacy
7.4. Retail Pharmacy

8. Pharmaceutical Continuous Manufacturing Market, by Application

8.1. Introduction
8.2. Active Pharmaceutical Ingredient
8.3. Biologics
8.4. Dry Powders

9. Pharmaceutical Continuous Manufacturing Market, by End User

9.1. Introduction
9.2. Contract Manufacturing Organization
9.3. Pharmaceutical Companies

10. Americas Pharmaceutical Continuous Manufacturing Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Pharmaceutical Continuous Manufacturing Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Pharmaceutical Continuous Manufacturing Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. 3P Biopharmaceuticals S.L.U.
14.1.2. AC Immune SA
14.1.3. Chemtrix BV
14.1.4. Continuus Pharmaceuticals
14.1.5. Coperion GmbH
14.1.6. Corning Incorporated
14.1.7. Gebrüder Lödige Maschinenbau GmbH
14.1.8. Glatt GmbH
14.1.9. Hosokawa Micron Corporation
14.1.10. Korsch AG
14.1.11. L.B. Bohle Maschinen und Verfahren GmbH
14.1.12. Sanofi S.A.
14.1.13. Scott Equipment Company
14.1.14. Siemens AG
14.1.15. SK Biotek Co., Ltd.
14.1.16. Syntegon Technology GmbH
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET RESEARCH PROCESS
FIGURE 2. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2023 VS 2030
FIGURE 3. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET DYNAMICS
FIGURE 7. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 10. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 14. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 9. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTINUOUS BLENDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTINUOUS COATERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTINUOUS COMPRESSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTINUOUS DRYERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTINUOUS GRANULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 15. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DRY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 23. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. CANADA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. CANADA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 43. CANADA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 44. CANADA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. CANADA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. MEXICO PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. MEXICO PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 48. MEXICO PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 49. MEXICO PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. MEXICO PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. CHINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. CHINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 70. CHINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 71. CHINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. CHINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. INDIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. INDIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 75. INDIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 76. INDIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. INDIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. JAPAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. JAPAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 85. JAPAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 86. JAPAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. JAPAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. THAILAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. THAILAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 115. THAILAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 116. THAILAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. THAILAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 129. DENMARK PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. DENMARK PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 131. DENMARK PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 132. DENMARK PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. DENMARK PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. EGYPT PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. EGYPT PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 136. EGYPT PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 137. EGYPT PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. EGYPT PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. FINLAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. FINLAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 141. FINLAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 142. FINLAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. FINLAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. FRANCE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. FRANCE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 146. FRANCE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 147. FRANCE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. FRANCE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. GERMANY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. GERMANY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 151. GERMANY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 152. GERMANY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. GERMANY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. ITALY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. ITALY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 161. ITALY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 162. ITALY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. ITALY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. NORWAY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. NORWAY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 176. NORWAY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 177. NORWAY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. NORWAY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. POLAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. POLAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 181. POLAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 182. POLAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. POLAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. QATAR PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. QATAR PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 186. QATAR PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 187. QATAR PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. QATAR PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. SPAIN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. SPAIN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 206. SPAIN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 207. SPAIN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. SPAIN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. TURKEY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. TURKEY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 221. TURKEY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 222. TURKEY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. TURKEY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY SEMI-CONTINUOUS SYSTEMS, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 235. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 236. PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET LICENSE & PRICING

Companies Mentioned

3P Biopharmaceuticals S.L.U. 
AC Immune SA
Chemtrix BV
Continuus Pharmaceuticals
Coperion GmbH
Corning Incorporated
Gebrüder Lödige Maschinenbau GmbH
Glatt GmbH
Hosokawa Micron Corporation
Korsch AG
L.B. Bohle Maschinen und Verfahren GmbH
Sanofi S.A.
Scott Equipment Company
Siemens AG
SK Biotek Co., Ltd.
Syntegon Technology GmbH

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	186
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 753.86 Million
Forecasted Market Value ( USD ) by 2030	$ 1537.65 Million
Compound Annual Growth Rate	12.6%
Regions Covered	Global
No. of Companies Mentioned	16

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,804GBP €3624EUR$3,749USD£3,115GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4132EUR$4,274USD£3,551GBP €4591EUR$4,749USD£3,946GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5002EUR$5,174USD£4,299GBP €5558EUR$5,749USD£4,777GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5872EUR$6,074USD£5,047GBP €6524EUR$6,749USD£5,608GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7612EUR$7,874USD£6,543GBP €8458EUR$8,749USD£7,270GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Pharmaceutical Continuous Manufacturing Global Market Report 2024

Global Pharmaceutical Continuous Manufacturing Market 2024-2028

Pharmaceutical Continuous Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Continuous Manufacturing - Global Strategic Business Report

ICH Q13: Continuous Manufacturing - Final Version of Guideline (Recorded)

About the Pharmaceutical Continuous Manufacturing Market